{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:21:11Z","timestamp":1786980071955,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00384-021-03947-1","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T14:02:54Z","timestamp":1620828174000},"page":"1861-1869","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["False-positive fecal immunochemical test results in colorectal cancer screening and gastrointestinal drug use"],"prefix":"10.1007","volume":"36","author":[{"given":"M. J.","family":"Domper Arnal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Garc\u00eda Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hermoso-Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Carrera-Lasfuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Velazquez-Campoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Abian Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,12]]},"reference":[{"key":"3947_CR1","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893\u20132917","journal-title":"Int J Cancer"},{"key":"3947_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/epirev\/mxr004","volume":"33","author":"I Lansdorp-Vogelaar","year":"2011","unstructured":"Lansdorp-Vogelaar I, Knudsen AB, Brenner H (2011) Cost-effectiveness of colorectal cancer screening. Epidemiol Rev 33:88\u2013100","journal-title":"Epidemiol Rev"},{"key":"3947_CR3","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.3748\/wjg.v23.i20.3632","volume":"23","author":"M Navarro","year":"2017","unstructured":"Navarro M, Nicolas A, Ferrandez A, Lanas A (2017) Colorectal cancer population screening programs worldwide in 2016: an update. World J Gastroenterol 23:3632\u20133642","journal-title":"World J Gastroenterol"},{"key":"3947_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s10620-014-3445-3","volume":"60","author":"GP Young","year":"2015","unstructured":"Young GP, Symonds EL, Allison JE, Cole SR, Fraser CG, Halloran SP, Kuipers EJ, Seaman HE (2015) Advances in fecal occult blood tests: the FIT revolution. Dig Dis Sci 60:609\u2013622","journal-title":"Dig Dis Sci"},{"key":"3947_CR5","doi-asserted-by":"crossref","unstructured":"Ib\u00e1\u00f1ez-Sanz, G., Garcia M., Rodr\u00edguez-Moranta F., Binefa G., G\u00f3mez-Matas J., Dom\u00e8nech X., Vidal C., Soriano A., Moreno V., \u2018Adverse Effects on Colorectal Cancer Screening in Catalonia (EACC) Study\u2019 Working Group (2016) Prescription drugs associated with false-positive results when using faecal immunochemical tests for colorectal cancer screening. Dig Liver Dis 48:1249\u20131254","DOI":"10.1016\/j.dld.2016.06.011"},{"key":"3947_CR6","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/gutjnl-2014-308074","volume":"64","author":"J Tinmouth","year":"2015","unstructured":"Tinmouth J, Lansdorp-Vogelaar I, Allison JE (2015) Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Gut 64:1327\u20131337","journal-title":"Gut"},{"key":"3947_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1258\/jms.2012.012013","volume":"19","author":"M Garcia","year":"2012","unstructured":"Garcia M, Mil\u00e0 N, Binefa G, Borr\u00e0s JM, Espin\u00e0s JA, Moreno V (2012) False-positive results from colorectal cancer screening in Catalonia (Spain), 2000-2010. J Med Screen 19:77\u201382","journal-title":"J Med Screen"},{"key":"3947_CR8","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1038\/s41395-018-0212-7","volume":"113","author":"CM de Klerk","year":"2018","unstructured":"de Klerk CM, Vendrig LM, Bossuyt PM, Dekker E (2018) Participant-related risk factors for false-positive and false-negative fecal immunochemical tests in colorectal cancer screening: systematic review and meta-analysis. Am J Gastroenterol 113:1778\u20131787","journal-title":"Am J Gastroenterol"},{"key":"3947_CR9","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1002\/ijc.28242","volume":"133","author":"I Stegeman","year":"2013","unstructured":"Stegeman I, de Wijkerslooth TR, Stoop EM, van Leerdam M, van Ballegooijen M, Kraaijenhagen RA, Fockens P, Kuipers EJ, Dekker E, Bossuyt PM (2013) Risk factors for false positive and for false negative test results in screening with fecal occult blood testing. Int J Cancer 133:2408\u20132414","journal-title":"Int J Cancer"},{"key":"3947_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/MEG.0b013e3283438aac","volume":"23","author":"G Mandelli","year":"2011","unstructured":"Mandelli G, Radaelli F, Paggi S, Terreni N, Gola G, Gramegna M, Bonaffini A, Terruzzi V (2011) Anticoagulant or aspirin treatment does not affect the positive predictive value of an immunological fecal occult blood test in patients undergoing colorectal cancer screening: results from a nested in a cohort case-control study. Eur J Gastroenterol Hepatol 23:323\u2013326","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3947_CR11","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/den.12208","volume":"26","author":"Y Tsuji","year":"2014","unstructured":"Tsuji Y, Gunji T, Sato H, Ono A, Ito T, Ohata K, Yamamichi N, Fujishiro M, Matsuhashi N, Koike K (2014) Antithrombotic drug does not affect the positive predictive value of an immunochemical fecal occult blood test. Dig Endosc 26:424\u2013429","journal-title":"Dig Endosc"},{"key":"3947_CR12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.amjmed.2004.05.028","volume":"117","author":"CJ Kahi","year":"2004","unstructured":"Kahi CJ, Imperiale TF (2004) Do aspirin and nonsteroidal anti-inflammatory drugs cause false-positive fecal occult blood test results? A prospective study in a cohort of veterans. Am J Med 117:837\u2013841","journal-title":"Am J Med"},{"key":"3947_CR13","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.cgh.2014.11.007","volume":"13","author":"A Lanas","year":"2015","unstructured":"Lanas A et al (2015) Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants. Clin Gastroenterol Hepatol 13:906\u2013912.e2","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3947_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0203359","volume":"13","author":"L Rodriguez-Alonso","year":"2018","unstructured":"Rodriguez-Alonso L et al (2018) Proton pump inhibitors reduce the accuracy of faecal immunochemical test for detecting advanced colorectal neoplasia in symptomatic patients. PLoS One 13:1\u201311","journal-title":"PLoS One"},{"key":"3947_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1365-2036.2007.03541.x","volume":"27","author":"YK Loke","year":"2008","unstructured":"Loke YK, Trivedi AN, Singh S (2008) Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 27:31\u201340","journal-title":"Aliment Pharmacol Ther"},{"key":"3947_CR16","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/ajg.2014.82","volume":"109","author":"R Anglin","year":"2014","unstructured":"Anglin R, Yuan Y, Moayyedi P, Tse F, Armstrong D, Leontiadis GI (2014) Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis. Am J Gastroenterol 109:811\u2013819","journal-title":"Am J Gastroenterol"},{"key":"3947_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar4175","volume":"15","author":"C Sostres","year":"2013","unstructured":"Sostres C, Gargallo CJ, Lanas A (2013) Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. Arthritis Res Ther 15:1\u20138","journal-title":"Arthritis Res Ther"},{"key":"3947_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.amjmed.2005.03.044","volume":"119","author":"VL Serebruany","year":"2006","unstructured":"Serebruany VL (2006) Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something? Am J Med 119:113\u2013116","journal-title":"Am J Med"},{"key":"3947_CR19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.dld.2018.12.008","volume":"51","author":"NH Kim","year":"2019","unstructured":"Kim NH, Lim JW, Kim S, Lim JY, Kim W, Park JH, Park DI, Sohn CI, Jung YS (2019) Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin concentration with risk of advanced colorectal neoplasia. Dig Liver Dis 51:589\u2013594","journal-title":"Dig Liver Dis"},{"key":"3947_CR20","first-page":"1","volume":"4","author":"A Lanas","year":"2018","unstructured":"Lanas A et al (2018) Non-variceal upper gastrointestinal bleeding. Nat Rev Dis Prim 4:1\u201321","journal-title":"Nat Rev Dis Prim"},{"key":"3947_CR21","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.gastrohep.2018.07.012","volume":"41","author":"J Cubiella","year":"2018","unstructured":"Cubiella J, Marzo-Castillejo M, Mascort-Roca JJ, Amador-Romero FJ, Bellas-Beceiro B, Clofent-Vilaplana J, Carballal S, Ferr\u00e1ndiz-Santos J, Gimeno-Garc\u00eda AZ, Jover R, Mangas-Sanju\u00e1n C, Moreira L, Pellis\u00e8 M, Quintero E, Rodr\u00edguez-Camacho E, Vega-Villaamil P, Sociedad Espa\u00f1ola de Medicina de Familia y Comunitaria y Asociaci\u00f3n Espa\u00f1ola de Gastroenterolog\u00eda (2018) Clinical practice guideline. Diagnosis and prevention of colorectal cancer. 2018 Update. Gastroenterol Hepatol 41:585\u2013596","journal-title":"Gastroenterol Hepatol"},{"key":"3947_CR22","doi-asserted-by":"crossref","unstructured":"van Leerdam ME et al (2019) Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 51","DOI":"10.1055\/a-1016-4977"},{"key":"3947_CR23","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1038\/ajg.2017.212","volume":"112","author":"P Kanth","year":"2017","unstructured":"Kanth P, Grimmett J, Champine M, Burt R, Samadder NJ (2017) Hereditary colorectal polyposis and cancer syndromes: a primer on diagnosis and management. Am J Gastroenterol 112:1509\u20131525","journal-title":"Am J Gastroenterol"},{"key":"3947_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1136\/gutjnl-2019-319858","volume":"69","author":"MD Rutter","year":"2020","unstructured":"Rutter MD, East J, Rees CJ, Cripps N, Docherty J, Dolwani S, Kaye PV, Monahan KJ, Novelli MR, Plumb A, Saunders BP, Thomas-Gibson S, Tolan DJM, Whyte S, Bonnington S, Scope A, Wong R, Hibbert B, Marsh J, Moores B, Cross A, Sharp L (2020) British Society of Gastroenterology\/Association of Coloproctology of Great Britain and Ireland\/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines. Gut 69:201\u2013223","journal-title":"Gut"},{"key":"3947_CR25","doi-asserted-by":"crossref","unstructured":"Hassan C et al (2019) Correction: endoscopic surveillance after surgical or endoscopic resection for colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Digestive Oncology (ESDO) Guideline (Endoscopy (2019) 51 DOI: 10.1055\/a-0831-25). Endoscopy 51(C1)","DOI":"10.1055\/a-0854-5925"},{"key":"3947_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/2050640617700014","volume":"5","author":"MF Kaminski","year":"2017","unstructured":"Kaminski MF, Thomas-Gibson S, Bugajski M, Bretthauer M, Rees CJ, Dekker E, Hoff G, Jover R, Suchanek S, Ferlitsch M, Anderson J, Roesch T, Hultcranz R, Racz I, Kuipers EJ, Garborg K, East JE, Rupinski M, Seip B, Bennett C, Senore C, Minozzi S, Bisschops R, Domagk D, Valori R, Spada C, Hassan C, Dinis-Ribeiro M, Rutter MD (2017) Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. United European Gastroenterol J 5:309\u2013334","journal-title":"United European Gastroenterol J"},{"key":"3947_CR27","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.gie.2008.05.057","volume":"69","author":"EJ Lai","year":"2009","unstructured":"Lai EJ, Calderwood AH, Doros G, Fix OK, Jacobson BC (2009) The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research. Gastrointest Endosc 69:620\u2013625","journal-title":"Gastrointest Endosc"},{"key":"3947_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.gastrohep.2018.11.001","volume":"42","author":"C Mangas-Sanjuan","year":"2019","unstructured":"Mangas-Sanjuan C, Jover R, Cubiella J, Marzo-Castillejo M, Balaguer F, Bessa X, Bujanda L, Bustamante M, Castells A, Diaz-Tasende J, D\u00edez-Redondo P, Herr\u00e1iz M, Mascort-Roca JJ, Pellis\u00e9 M, Quintero E, Grupo de Cribado del C\u00e1ncer Colorrectal de la Sociedad Espa\u00f1ola de Epidemiolog\u00eda (2019) Endoscopic surveillance after colonic polyps and colorrectal cancer resection. 2018 update. Gastroenterol Hepatol 42:188\u2013201","journal-title":"Gastroenterol Hepatol"},{"key":"3947_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-014-0151-0","volume":"31","author":"M Ferlitsch","year":"2014","unstructured":"Ferlitsch M et al (2014) Sex is a stronger predictor of colorectal adenoma and advanced adenoma than fecal occult blood test. Med Oncol 31:1\u20137","journal-title":"Med Oncol"},{"key":"3947_CR30","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1136\/gut.2007.122739","volume":"56","author":"H Brenner","year":"2007","unstructured":"Brenner H, Hoffmeister M, Stegmaier C, Brenner G, Altenhofen L, Haug U (2007) Risk of progression of advanced adenomas to colorectal cancer by age and sex: Estimates based on 840 149 screening colonoscopies. Gut 56:1585\u20131589","journal-title":"Gut"},{"key":"3947_CR31","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1177\/2050640616659998","volume":"5","author":"EJ Grobbee","year":"2017","unstructured":"Grobbee EJ, Wieten E, Hansen BE, Stoop EM, Wijkerslooth TR, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E, Kuipers EJ, Spaander MCW (2017) Fecal immunochemical test-based colorectal cancer screening: the gender dilemma. United European Gastroenterol J 5:448\u2013454","journal-title":"United European Gastroenterol J"},{"key":"3947_CR32","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/14740338.2019.1664470","volume":"18","author":"A Lanas-Gimeno","year":"2019","unstructured":"Lanas-Gimeno A, Hijos G, Lanas \u00c1 (2019) Proton pump inhibitors, adverse events and increased risk of mortality. Expert Opin Drug Saf 18:1043\u20131053","journal-title":"Expert Opin Drug Saf"},{"key":"3947_CR33","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.cgh.2015.10.022","volume":"14","author":"E Washio","year":"2016","unstructured":"Washio E et al (2016) Proton pump inhibitors increase incidence of nonsteroidal anti-inflammatory drug-induced small bowel injury: a randomized, placebo-controlled trial. Clin Gastroenterol Hepatol 14:809\u2013815.e1","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3947_CR34","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/j.1365-2036.2007.03312.x","volume":"25","author":"JL Goldstein","year":"2007","unstructured":"Goldstein JL et al (2007) Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Aliment Pharmacol Ther 25:1211\u20131222","journal-title":"Aliment Pharmacol Ther"},{"key":"3947_CR35","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1152\/ajpgi.00066.2015","volume":"308","author":"RW Blackler","year":"2015","unstructured":"Blackler RW et al (2015) Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID. Am J Physiol Gastrointest Liver Physiol 308:994\u20131003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3947_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-53559-7","volume":"9","author":"Y Nadatani","year":"2019","unstructured":"Nadatani Y et al (2019) Gastric acid inhibitor aggravates indomethacin-induced small intestinal injury via reducing Lactobacillus johnsonii. Sci Rep 9:1\u201311","journal-title":"Sci Rep"},{"key":"3947_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-018-6019-z","volume":"18","author":"I G\u00f3mez-Acebo","year":"2018","unstructured":"G\u00f3mez-Acebo I et al (2018) Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study. BMC Public Health 18:1\u201313","journal-title":"BMC Public Health"}],"updated-by":[{"DOI":"10.1007\/s00384-021-03965-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000}}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-021-03947-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-021-03947-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-021-03947-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T16:06:02Z","timestamp":1628265962000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-021-03947-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,12]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["3947"],"URL":"https:\/\/doi.org\/10.1007\/s00384-021-03947-1","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,12]]},"assertion":[{"value":"27 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2021","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00384-021-03965-z","URL":"https:\/\/doi.org\/10.1007\/s00384-021-03965-z","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and approved by the Ethical and Scientific Committee of Aragon (Spain) with the code of approbation: PI19\/059. In line with this, all study participants, or their legal guardians, provided informed written consent prior to the study enrollment. Moreover, the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}